Your new post is loading...
Vaccine-based cancer immunotherapy has generated highly variable clinical results due to differing methods of vaccine preparation and variation in patient populations, among other lesser factors. M...
Via Krishan Maggon
|
Rescooped by Gilbert C FAURE from Cancer Immunotherapy Review and Collection |
Scoop.it!
Via Krishan Maggon
MINI REVIEW ARTICLEFront. Immunol., 28 January 2015 | doi: 10.3389/fimmu.2015.00013Natural killer cells as helper cells in dendritic cell cancer vaccinesMaría Betina Pampena and Estrella Mariel Levy*Centro de Investigaciones Oncológicas CIO-FUCA, Buenos Aires, Argentina